Singapore markets open in 4 hours 24 minutes

VTRS Jun 2024 13.000 put

OPR - OPR Delayed Price. Currency in USD
Add to watchlist
0.75000.0000 (0.00%)
As of 01:50PM EST. Market open.
Full screen
Previous close0.7500
Expiry date2024-06-21
Day's range0.7500 - 0.8000
Contract rangeN/A
Open interest348

    Chris Davis Reduces Stake in Viatris Inc

    Chris Davis (Trades, Portfolio), through Davis Advisors, has recently adjusted the firm's holdings in the pharmaceutical company Viatris Inc (NASDAQ:VTRS). On December 31, 2023, the firm reduced its stake in Viatris by 1,402,057 shares. This transaction has altered the landscape of Davis Advisors' investment portfolio, reflecting a strategic move by the firm in the pharmaceutical sector.

  • Zacks

    Embecta Corp. (EMBC) Surpasses Q1 Earnings and Revenue Estimates

    Embecta Corp. (EMBC) delivered earnings and revenue surprises of 35.56% and 4.15%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?

  • PR Newswire

    Viatris to Announce Fourth Quarter and Full-Year 2023 Financial Results

    Viatris Inc. (NASDAQ: VTRS) will announce its fourth quarter and full-year 2023 financial results Wednesday, Feb. 28, 2024, before the open of the U.S. financial markets. Chief Executive Officer Scott A. Smith and Company executives will host a webcast at 8:30 a.m. ET on the same date to discuss the results.